Cancer of the colon in an egg donor: Policy repercussions for donor recruitment

Human Reproduction

Volumn 13, Issue 1, 1998, Pages 227-231

  Ahuja, K K ^a   Simons, E G ^a  

^a CROMWELL HOSPITAL   (United Kingdom)

Author keywords

Altruism; Cancer; Donor payments; Egg donation; Fertility drugs

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL INSEMINATION; CASE REPORT; COLON CANCER; FEMALE; GAMETE; HEALTH CARE POLICY; HUMAN; HUMAN CELL; INCOME; MEDICAL ETHICS; MEDICAL PRACTICE; MORALITY; OOCYTE DONATION; RISK; SAFETY;

EID: 0031931753     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.1.227     Document Type: Article

References (60)

1. Abdalla, H.I. (1996) A national oocyte donation society is needed. Hum. Reprod., 11, 2355-2356.
2. Agrawal, R., West, C., Conway, O.S. et al. (1997) Pregnancy after treatment with three recombinant gonadotrophins. Lancet, 349, 29-30.
3. Ahuja, K.K. and Simons, E.G. (1996) Anonymous egg donation and dignity. Hum. Reprod., 11, J151-1154.
4. th Annual Conference of the American Society of Reproductive Medicine, October 1997.
5. Ahuja, K.K., Simons, E.G., Fiamanya, W. et al. (1996) Egg sharing in assisted conception: ethical and practical considerations. Hum. Reprod., 11, 1126-1131.
6. Aurousseau, M.H., Samama, M.M., Balhassen, A. et al. (1995) Risk of thromboembolism in relation to an in-vitro fertilization programme. Hum. Reprod., 10, 94-97.
7. Balasch, J., Pahisa, J., Marquez, M. et al. (1993) Metastatic ovarian stromosis in an in-vitro fertilization patient. Hum. Reprod., 8, 2075-2077.
8. Bandera, C.A., Cramer, D.W., Friedman, A.J. and Sheets, E.E. (1995) Fertility therapy in the setting of a history of invasion epithelial ovarian cancer. Genaecol Oncol., 58, 1, 116-119.
9. Ben-Chetrit, A.U. and Ben-Chetrit, E. (1994) Systemic lupus erythematosus induced by ovulation induction treatment. Arthr. Rheumat., 37, 1614-1617.
10. Borini, A., Bianchi, L. and Violini, F. (1996) Oocyte donation programme; pregnancy and implantation rates in women of different ages sharing oocytes from single donors. Fertil. Steril., 65, 94-97.
11. Bristow, R.E. and Kaplan, B.Y. (1996a) The risk of ovarian cancer after treatment of infertility. Curr. Opin. Obstet. Gynaecol., 8, 32-37.
12. Bristow, R.E. and Kaplan, B.Y. (1996b) Ovulation induction, infertility and ovarian cancer risk. Fertil. Steril., 66, 499-507.
13. British Andrology Society (1997) Response to the HFEA paper, Payment of semen donors.
14. British Fertility Society (1996) Response to the HFEA paper, Payment of sperm donors.
15. Bezezinski, A., Peretz, T., Mor-Yosef, S. and Shenker, J.G. (1994) Ovarian stimulation and breast cancer: is there a link? Gynaecol. Oncol., 52, 292-295.
16. Canadian Royal Commission on New Reproductive Technologies (1993) Proceed with care. Final report of the Royal Commission on New Reproductive Technologies.
17. Check, J.H., Akasi, H.A., Fisher, C. and Vanamann, L. (1994) The use of shared oocyte programme to evaluate the effect of uterine senescence. Fertil. Steril., 61, 252-255.
18. Chou, H., Lai, C., Hsuch, S. and Soong, Y-K. (1997) Sertoli-Leydig cell tumour in an infertile patient after stimulated ovulation. Hum. Reprod., 12, 1021-1023.
19. Cooke, I.L. (1996) Response to the HFEA paper, Payment to sperm donors. Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent's Park, London, NWJ 4RG.
20. Craft, I. (1997) Should egg donors be paid? An 'inconvenience allowance' would solve the egg shortage. Brit. Med. J., 314, 1400-1401.
21. nd Annual Meeting of the American Society for Reproductive Medicine (suppl.) pp. 147.
22. Edwards, R.G., Lobo, R. and Bouchard, P. (1996) Time to revolutionize ovarian stimulation. Hum. Reprod., 11, 917-919.
23. Englert, Y. (I996) Ethics of oocyte donation are challenged by the health care system. Hum. Reprod., 11, 2353-2357.
24. Faber, B., Harnacher, P. and Toner, J.P. (1996) Pregnancy rates are similar for egg donors and their recipients when donor eggs are shared. 52nd Annual meeting of the American Society for Reproductive Medicine (suppl.), p. 23.
25. Fishel, S. and Jackson, P. (1989) Follicular stimulation for high tech pregnancies: are we playing it safe? Brit. Med. J., 299, 309-311.
26. Golombok, S. (1996) What about the children? Organon Fertil. Suppl., pp 57-62.
27. Grimbizis, G., Tarlatzis, B.C., Bontis, J. et al. (1995) Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts. Hum. Reprod., 10, 520-523.
28. Howles, C.M. (1996) Genetic engineering of human FSH (Gonal-F). Hum. Reprod., 2, 1-32.
29. Johnson, M.H. (1997) Should egg donors be paid? The culture of unpaid and voluntary egg donation should be strengthened. Brit. Med. J., 314, 1401-1402.
30. Kamatsue, T., Konishi, I., Mandai, M. et al. (1995) Peritoneal papillary serum carcinoma arising in an infertile woman during ovulation induction therapy. Gynaecol. Oncol., 56, 470-474.
31. Kuppens, E., Bergman, W., Welvaart, K. et al. (1992) Multiple primary melanomas in a patient with familial-type DNS during clomiphene-induced pregnancy. Melanoma Res., 2(1), 71-74.
32. Land, J.A. (1993) Ovulation, ovulation induction and ovarian carcinoma. Clin. Obstet. Gynaecol., 7, 2, 455-472.
33. Lockwood, G.M. (1997) Donating life: practical and ethical issues in gamete donation. In Shenfield, F. and Sureau, C. (eds) Ethical dilemmas in assisted reproduction. Parthenon, London, pp. 23-30.
34. McLaughlin, H.A., Harrison, S., Mitchell, J. and Hull, M. (1997) Payments for sperm donors are justified. The Sunday Times, London, 24 August 1997.
35. Miannay, E., Bontemy, J.J., Leroy-Billiard, M. et al. (1994) The possible endometrial risk of ovarian stimulation. J. Gynaecol. Obstet. Biol. Reprod., 23(1), 35-38.
36. Morris, R.S., Erving, C., Carey, R. and Dudkiewicz, A. (1996) Prevalence and importance of occult ovarian failure in oocyte donors. 52nd Annual meeting of the American society for Reproductive Medicine (suppl.), p. 143.
37. Mosgaard, B.J., Lidegaard, O., Kjaer, S.K. et al. (1997) Ovarian stimulation and borderline ovarian tumours: a case continue study. Hum. Reprod., abst. 012.
38. National Institute of Health (1994) Report of the Human Embryo Research Panel, September 27, Bethesda, USA.
39. National Statistics (1996) Registrations of cancer diagnosed in 1991, England and Wales. Monitor. Population and health publications unit office for national statistics.
40. Nijman, H.W., Berger, C.W., Baak, J.P. and Senats, R. (1992) Borderline malignancy of the ovary and controlled hyperstimulation. Eur. J. Cancer, 28A(12), 1971-1973.
41. Out, H.J., Mannaerts, B.M.J.L., Driessen, S.G.A.J. et al. (1996) Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Excerpts Hum. Reprod., 1, 38-47.
42. Ranee, A., Emrnerich, J., Guedi, C. and Flesinger, J.N. (1997) Occult cancer in patients with bilateral deep vein thrombosis. Lancet, 350, 1448-49, 1997.
43. Ridley, M. (1997) Acid Test. The Daily Telegraph, London, 30 June 1997.
44. Rossing, M.A., Darling, J.R. and Weiss, N.S. (1994) Ovarian tumours in a cohort of infertile women. N. Eng. J. Med., 331, 771-776.
45. Salle, B., Hilaire, P.S., Devouassoux, M. et al. (1997) Another two cases of ovarian tumours in women who had undergone multiple ovulation induction cycles. Hum. Reprod., 12, 1732-1736.
46. Salha, O., Martin-Hirsch, P., Lane, G. and Sharma, V. (1997) Endometrial carcinoma in a young patient with polycystic ovarian syndrome: first suspected at time of embryo transfer. Hum. Reprod., 12, 959-962.
47. Sauer, M.V. (1997) Should egg donors be paid? Exploitation or a woman's right? Brit. Med. J., 314, 1403.
48. Saunders, D.M. and Garner, F. (1996) Oocyte donation using known donors: it may seem the convenient answer but who pays? Hum. Reprod., 11, 2356-2357.
49. Shenfield, F. (1996) Cancer risk and fertility treatments: a question of informed consent. J. Fertil. Counselling, 15-16.
50. Shushan, A., Paltiel, O., Iscorich, J. et al. (1996) Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil. Steril., 65, 13-18.
51. Stewart, J.A., Hamilton, P.J. and Murdoch, A.P. (1997) Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Hum. Reprod., 12, 2167-2173.
52. Sung, L., Karstaedt, A., Mukherjee, T. et al. (1996) Sisters of women with premature ovarian failure may not be ideal ovum donors. 52nd Annual Meeting of the American Society for Reproductive Medicine, p. 070.
53. Vanthier-Bronzes, D., Lefebuze, G., Seebacher, J. and Wechsler, B. (1993) Internal jugular vein thrombosis during pregnancy after ovarian hyperstimulation for in vitro fertilisation. Contraception, Fertilité, Sexualité, 21(1), 33-35.
54. Venn, A., Watson, L., Lumley, J. et al. (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet, 346, 995-998.
55. Warnock Report (1984) Report of the Committee of Enquiry into Human Fertilization and Embryology. HMSO, London.
56. Waterstone, J. and Parson, S.J. (1992) Endometrial stromal sarcoma two years after a successful in vitro fertilisation treatment cycle. Hum. Reprod., 7, 72.
57. Whittermore, A.S. (1994) The risk of ovarian cancer after treatment of infertility. N. Eng. J. Med., 331, 805-806.
58. Willemsen, W., Kruitwagen, R., Bartiaans, B. et al. (1993) Ovarian stimulation and granulosa-cell tumour. Lancet, 341, 986-988,
59. World in Action (1996) Bobby Moore and me. Granada Television, 22 July 1996.
60. Yaron, Y., Amit, A. and Brenner, S.M. (1995) In vitro fertilisation and oocyte donation in women 45 years of age and older. Fertil. Steril., 63, 71.